4D Molecular Therapeutics (4DMT) IPO

4dmoleculartherapeutics.com

4DMT is a biotechnology company focused on pioneering the development of precision gene therapies based on proprietary AAV vectors.

Founded2013
Total Funding to Date$109MM
Register for Details

For more details on financing and valuation for 4D Molecular Therapeutics (4DMT), register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

4D Molecular Therapeutics (4DMT) Ticker Symbol

FDMT

4D Molecular Therapeutics (4DMT) Stock Price

$21.81 as of 12/6/22